
<!DOCTYPE html><!--[if lt IE 9]><html class="no-js lt-ie9" lang="en" dir="ltr"><![endif]--><!--[if gt IE 8]><!-->
<html class="no-js" lang="en" dir="ltr">
<!--<![endif]-->
<head>
<meta charset="utf-8">
<!-- Web Experience Toolkit (WET) / Boîte à outils de l'expérience Web (BOEW)
wet-boew.github.io/wet-boew/License-en.html / wet-boew.github.io/wet-boew/Licence-fr.html -->
<title>Abilify - Safety Summary Review</title>
<meta content="width=device-width,initial-scale=1" name="viewport">
<!-- Meta data -->
<meta name="description" content="Web Experience Toolkit (WET) includes reusable components for building and maintaining innovative Web sites that are accessible, usable, and interoperable. These reusable components are open source software and free for use by departments and external Web communities">
<!-- Meta data-->
<!--[if gte IE 9 | !IE ]><!-->
<link href=".././assets/favicon.ico" rel="icon" type="image/x-icon">
<link rel="stylesheet" href=".././css/wet-boew.min.css">
<!--<![endif]-->
<link rel="stylesheet" href=".././css/theme.min.css">
<!--[if lt IE 9]>
<link href=".././assets/favicon.ico" rel="shortcut icon" />

<link rel="stylesheet" href=".././css/ie8-wet-boew.min.css" />
<script src="http://ajax.googleapis.com/ajax/libs/jquery/1.11.1/jquery.min.js"></script>
<script src=".././js/ie8-wet-boew.min.js"></script>
<![endif]-->
<!--[if lte IE 9]>


<![endif]-->
<noscript><link rel="stylesheet" href=".././css/noscript.min.css" /></noscript>
<!-- Google Tag Manager DO NOT REMOVE OR MODIFY - NE PAS SUPPRIMER OU MODIFIER -->
<script>dataLayer1 = [];</script>
<!-- End Google Tag Manager -->
<!-- boostrap stuff-->
    <link rel="stylesheet" href="http://maxcdn.bootstrapcdn.com/bootstrap/3.3.5/css/bootstrap.min.css">
    <script src="https://ajax.googleapis.com/ajax/libs/jquery/1.11.3/jquery.min.js"></script>
    <script src="http://maxcdn.bootstrapcdn.com/bootstrap/3.3.5/js/bootstrap.min.js"></script>
</head>
<body vocab="http://schema.org/" typeof="WebPage">
<!-- Google Tag Manager DO NOT REMOVE OR MODIFY - NE PAS SUPPRIMER OU MODIFIER -->
<noscript><iframe title="Google Tag Manager" src="//www.googletagmanager.com/ns.html?id=GTM-TLGQ9K" height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
<script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start': new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0], j=d.createElement(s),dl=l!='dataLayer1'?'&l='+l:'';j.async=true;j.src='//www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);})(window,document,'script','dataLayer1','GTM-TLGQ9K');</script>
<!-- End Google Tag Manager -->
<ul id="wb-tphp">
<li class="wb-slc">
<a class="wb-sl" href="#wb-cont">Skip to main content</a>
</li>
<li class="wb-slc visible-sm visible-md visible-lg">
<a class="wb-sl" href="#wb-info">Skip to "About this site"</a>
</li>
</ul>
<header role="banner">
<div id="wb-bnr" class="container">
<section id="wb-lng" class="visible-md visible-lg text-right">
<h2 class="wb-inv">Language selection</h2>
<div class="row">
<div class="col-md-12">
<ul class="list-inline margin-bottom-none">
<li><a lang="fr" href="content-fr.html">Français</a></li>
</ul>
</div>
</div>
</section>
<div class="row">
<div class="brand col-xs-8 col-sm-9 col-md-6">
<a href="http://www.canada.ca/en/index.html"><object type="image/svg+xml" tabindex="-1" data=".././assets/sig-blk-en.svg"></object><span class="wb-inv"> Government of Canada</span></a>
</div>
<section class="wb-mb-links col-xs-4 col-sm-3 visible-sm visible-xs" id="wb-glb-mn">
<h2>Search and menus</h2>
<ul class="list-inline text-right chvrn">
<li><a href="#mb-pnl" title="Search and menus" aria-controls="mb-pnl" class="overlay-lnk" role="button"><span class="glyphicon glyphicon-search"><span class="glyphicon glyphicon-th-list"><span class="wb-inv">Search and menus</span></span></span></a></li>
</ul>
<div id="mb-pnl"></div>
</section>
<section id="wb-srch" class="col-xs-6 text-right visible-md visible-lg">
<h2 class="wb-inv">Search</h2>
<form action="#" method="post" name="cse-search-box" role="search" class="form-inline">
<div class="form-group">
<label for="wb-srch-q" class="wb-inv">Search website</label>
<input id="wb-srch-q" list="wb-srch-q-ac" class="wb-srch-q form-control" name="q" type="search" value="" size="27" maxlength="150" placeholder="Search Canada.ca">
<datalist id="wb-srch-q-ac">
<!--[if lte IE 9]><select><![endif]-->
<!--[if lte IE 9]></select><![endif]-->
</datalist>
</div>
<div class="form-group submit">
<button type="submit" id="wb-srch-sub" class="btn btn-primary btn-small" name="wb-srch-sub"><span class="glyphicon-search glyphicon"></span><span class="wb-inv">Search</span></button>
</div>
</form>
</section>
</div>
</div>
<nav role="navigation" id="wb-sm" class="wb-menu visible-md visible-lg" data-trgt="mb-pnl" data-ajax-fetch=".././ajax/sitemenu-en.html" typeof="SiteNavigationElement">
<h2 class="wb-inv">Topics menu</h2>
<div class="container nvbar">
<div class="row">
<ul class="list-inline menu">
<li><a href="http://www.esdc.gc.ca/en/jobs/index.page">Jobs</a></li>
<li><a href="http://www.cic.gc.ca/english/index.asp">Immigration</a></li>
<li><a href="http://travel.gc.ca/">Travel</a></li>
<li><a href="http://www.canada.ca/en/services/business/index.html">Business</a></li>
<li><a href="http://www.canada.ca/en/services/benefits/index.html">Benefits</a></li>
<li><a href="http://healthycanadians.gc.ca/index-eng.php">Health</a></li>
<li><a href="http://www.canada.ca/en/services/taxes/index.html">Taxes</a></li>
<li><a href="http://www.canada.ca/en/services/index.html">More services</a></li>
</ul>
</div>
</div>
</nav>
<nav role="navigation" id="wb-bc" class="" property="breadcrumb">
<h2 class="wb-inv">You are here:</h2>
<div class="container">
<div class="row">
<ol class="breadcrumb">
<li><a href="http://www.canada.ca/en/index.html">Home</a></li>
<li><a href="http://www.canada.ca/en/index.html">Summary Safety Reviews</a></li>
<li>Abilify</li>
</ol>
</div>
</div>
</nav>
</header>
<main role="main" property="mainContentOfPage" class="container">
<h1 property="name" id="wb-cont">Drug and Health Product Register</h1>
    <div>
      <ul class="nav nav-tabs">
        <li><a href="dhpr_option3d.html">Search for Drugs</a></li>
        
        <li class="active panel-title dropdown">
          <a class="dropdown-toggle" data-toggle="dropdown" href="#">Summary Reports
          <span class="caret"></span></a>
          <ul class="dropdown-menu">
            <li><a href="dhpr_rds_3d.html">Regulatory Decision Summaries (RDS)</a></li>
            <li><a href="dhpr_sbd_3d.html">Summary Basis of Decision (SBD)</a></li> 
            <li><a href="dhpr_ssr_3d.html">Summary Safety Reviews (SSR)</a></li>
          </ul>
        </li>
        <li><a href="dhpr_report_se.html">Report a Side Effect</a></li>
        <li class="dropdown">
          <a class="dropdown-toggle" data-toggle="dropdown" href="#">About
          <span class="caret"></span></a>
          <ul class="dropdown-menu">
            <li><a href="dhpr_option3d_whatsnew.html">What’s New?  </a></li>
            <li><a href="dhpr_about.html">The Drug and Health Product Register</a></li>
            <li><a href="/hpr-rps/templates/data-donnees-eng.html" tabindex="-1" aria-posinset="2" aria-setsize="5" role="menuitem">Data Sources</a></li>
            <li><a href="dhpr_se_disclaimer.html" tabindex="-1" aria-posinset="3" aria-setsize="5" role="menuitem">Reported Side Effects - Disclaimers</a></li>
            <li><a href="#" tabindex="-1" aria-posinset="4" aria-setsize="5" role="menuitem">Feedback</a></li>
            <li><a href="#" tabindex="-1" aria-posinset="5" aria-setsize="5" role="menuitem">Questions and Answers</a></li>
          </ul>
        </li>
      </ul>      
    </div>
<section>
        <h2>Abilify (donepezil) - Summary Safety Review </h2>


           <h3> Risk of Rhabdomyolysis and Neuroleptic Malignant Syndrome</h3>
        <p>January 21, 2015</p>
		<h3>Product</h3>
        <p>Galexos (simeprevir)</p>
        <details class="span-8"><summary><strong>Potential Safety Issue</strong></summary>
        <p>Severe liver problems</p>
        </details>
		<details class="span-8"><summary><strong>Key Messages</strong></summary>
<ul>
<li>Galexos (simeprevir) is a drug used to treat chronic hepatitis C.
</li><li>A safety review was carried out by Health Canada after Japan published a risk communication on severe liver problems and related death with simeprevir use.
</li><li>The prescribing information for Galexos has been updated with warnings about the risk of severe liver problems and related death. It also reminds healthcare professionals to frequently monitor patients for liver problems when using this drug.</li>
</ul>
		</details>
        <details class="span-8"><summary><strong>Overview</strong></summary>
        <p>This safety review was carried out by Health Canada after the publication of case reports of IAS (insulin autoimmune syndrome) causing hypoglycemic episodes linked with the use of oral alpha lipoic acid products in individuals with a genetic variation which causes the body's own defence system to attack insulin (insulin autoimmune syndrome).</p>
        </details>
		<details class="span-8"><summary><strong>Use in Canada</strong></summary>
        <ul><li>Alpha lipoic acid is a medicinal ingredient in some natural health products and is used as an antioxidant for the maintenance of good health and/or to help promote the healthy breakdown of glucose. It is also used as a preservative (non-medicinal ingredient) in some natural health products.</li>
		<li>At the time of the review, Health Canada had licensed over 800 natural health products containing alpha lipoic acid, also known as thioctic acid, as a medicinal ingredient for human use.</li>
		</ul>
		</details>
		<details class="span-8"><summary><strong>Safety Review Findings</strong></summary>
        <ul>
		<li>At the time of the review, there were no Canadian reports of hypoglycemic episodes reported with the use of alpha lipoic acid.
</li><li>There are several published international case reports of hypoglycemic episodes in individuals with IAS (insulin autoimmune syndrome) which may have been triggered by the use of oral products containing alpha lipoic acid. The cases of hypoglycemia resolved once the alpha lipoic acid was stopped.
</li><li>There is scientific evidence linking a genetic predisposition for IAS (insulin autoimmune syndrome) with the risk for developing hypoglycemic episodes with the use of oral alpha lipoic acid.
</li><li>Although most of these cases originate from Asia where these genetic variations are more common, cases have recently been reported in Europe as well. It is not known how common this specific genetic variation is within the Canadian population, which is multi-cultural and genetically varied.</li>
		</ul>
		</details>
        <details class="span-8"><summary><strong>Conclusions and Actions</strong></summary>
		<ul>
<li>Health Canada's safety review concluded that alpha lipoic acid may cause a condition known as IAS (insulin autoimmune syndrome), which can result in low blood sugar (hypoglycemia). This side effect seems to be rare and the reported cases happened in individuals with a specific genetic variation. The cases of hypoglycemia resolved once the alpha lipoic acid was stopped.
</li><li>Consumers may not be aware of the risk until they are exposed to alpha lipoic acid, therefore Health Canada is considering updates to the labelling standard for alpha lipoic acid to inform consumers to stop using the product and to consult a healthcare professional if they experience symptoms of low blood sugar such as sweating, paleness, chills, headache, dizziness and/or confusion.
</li><li>In addition, Health Canada will publish a Health Product InfoWatch article to raise awareness of this potential risk.
</li><li>Health Canada will continue to monitor safety information involving alpha lipoic acid, as it does for all health products on the Canadian market, to identify and assess potential harms. Health Canada will take appropriate and timely action if and when any new health risks are identified.</li>   
</ul> 
		</details>
        <details class="span-8"><summary><strong>Additional Information</strong></summary>
		<p>The analysis that contributed to this safety review included scientific and medical literature, Canadian and international adverse reaction reports and what is known about the use of this drug both in Canada and internationally.</p><p>For additional information, <a href="http://www.hc-sc.gc.ca/contact/dhp-mps/hpfb-dgpsa/mhp-psc-eng.php">contact the Marketed Health Products Directorate</a>.<u> </u></p>    
		</details>

</section>
<div class="form-group">
<div class="col-sm-offset-3 col-sm-9">

</div>
</div>
</form>
<div class="row pagedetails">
<div class="col-xs-6 datemod">
<dl id="wb-dtmd">
<dt>Date modified:&#32;</dt>
<dd><time property="dateModified">2015-01-21</time></dd>
</dl>
</div>
<div class="col-xs-6 text-right">
<a href="http://www.canada.ca/en/contact/feedback.html" class="btn btn-default"><span class="glyphicon glyphicon-comment mrgn-rght-sm"></span>Feedback<span class="wb-inv"> about this web site</span></a>
</div>
</div>
</main>

<footer role="contentinfo" id="wb-info">
<nav role="navigation" class="container visible-sm visible-md visible-lg wb-navcurr">
<h2 class="wb-inv">About this site</h2>
<div class="row">
<div class="col-sm-3 col-lg-3">
<section>
<h3>Contact information</h3>
<ul class="list-unstyled">
<li><a href="#">Link 1</a></li>
<li><a href="#">Link 2</a></li>
<li><a href="#">Link 3</a></li>
</ul>
</section>
<section>
<h3>News</h3>
<ul class="list-unstyled">
<li><a href="http://news.gc.ca/web/index-en.do">Newsroom</a></li>
<li><a href="http://news.gc.ca/web/nwsprdct-en.do?mthd=tp&amp;crtr.tp1D=1">News releases</a></li>
<li><a href="http://news.gc.ca/web/nwsprdct-en.do?mthd=tp&amp;crtr.tp1D=3">Media advisories</a></li>
<li><a href="http://news.gc.ca/web/nwsprdct-en.do?mthd=tp&amp;crtr.tp1D=970">Speeches</a></li>
<li><a href="http://news.gc.ca/web/nwsprdct-en.do?mthd=tp&amp;crtr.tp1D=980">Statements</a></li>
</ul>
</section>
</div>
<section class="col-sm-3 col-lg-3">
<h3>Government</h3>
<ul class="list-unstyled">
<li><a href="http://www.canada.ca/en/gov/system/index.html">How government works</a></li>
<li><a href="http://www.canada.ca/en/gov/dept/index.html">Departments &amp; agencies</a></li>
<li><a href="http://pm.gc.ca/eng">Prime Minister</a></li>
<li><a href="http://www.canada.ca/en/gov/ministers/index.html">Ministers</a></li>
<li><a href="http://www.canada.ca/en/gov/policy/index.html">Policies, regulations &amp; laws</a></li>
<li><a href="http://www.canada.ca/en/gov/libraries/index.html">Libraries</a></li>
<li><a href="http://www.canada.ca/en/gov/publications/index.html">Publications</a></li>
<li><a href="http://www.canada.ca/en/gov/statistics/index.html">Statistics &amp; data</a></li>
<li><a href="http://www.canada.ca/en/newsite.html">About Canada.ca</a></li>
</ul>
</section>
<section class="col-sm-3 col-lg-3 brdr-lft">
<h3>Transparency</h3>
<ul class="list-unstyled">
<li><a href="http://www.canada.ca/en/transparency/reporting.html">Government-wide reporting</a></li>
<li><a href="http://open.canada.ca/en/">Open government</a></li>
<li><a href="http://www.canada.ca/en/transparency/disclosure.html">Proactive disclosure</a></li>
<li><a href="http://www.canada.ca/en/transparency/terms.html">Terms &amp; conditions</a></li>
<li><a href="http://www.canada.ca/en/transparency/privacy.html">Privacy</a></li>
</ul>
</section>
<div class="col-sm-3 col-lg-3 brdr-lft">
<section>
<h3>Feedback</h3>
<p><a href="http://www.canada.ca/en/contact/feedback.html"><img src=".././assets/feedback.png" alt="Feedback about this Web site"></a></p>
</section>
<section>
<h3>Social media</h3>
<p><a href="http://www.canada.ca/en/social/index.html"><img src=".././assets/social.png" alt="Social media"></a></p>
</section>
<section>
<h3>Mobile centre</h3>
<p><a href="http://www.canada.ca/en/mobile/index.html"><img src=".././assets/mobile.png" alt="Mobile centre"></a></p>
</section>
</div>
</div>
</nav>
<div class="brand">
<div class="container">
<div class="row">
<div class="col-xs-6 visible-sm visible-xs tofpg">
<a href="#wb-cont">Top of Page <span class="glyphicon glyphicon-chevron-up"></span></a>
</div>
<div class="col-xs-6 col-md-12 text-right">
<object type="image/svg+xml" tabindex="-1" role="img" data=".././assets/wmms-blk.svg" aria-label="Symbol of the Government of Canada"></object>
</div>
</div>
</div>
</div>
</footer>
<!--[if gte IE 9 | !IE ]><!-->
<script src="http://ajax.googleapis.com/ajax/libs/jquery/2.1.1/jquery.min.js"></script>
<script src=".././js/wet-boew.min.js"></script>
<!--<![endif]-->
<!--[if lt IE 9]>
<script src=".././js/ie8-wet-boew2.min.js"></script>
<![endif]-->
<script src=".././js/theme.min.js"></script>
</body>
</html>

